Normokalemic and Hypokalemic Periodic Paralysis Coexist in a Family with a Novel R1129Q Mutation in the SCN4A Gene

洪道俊,栾兴华,郑日亮,陈彬,张巍,王朝霞,袁云
DOI: https://doi.org/10.3760/cma.j.issn.1006-7876.2009.09.006
2009-01-01
Abstract:Objective To describe the clinical and myopathological phenotype of periodic paralysis in a family associated with a novel mutation in the skeletal muscle sodium channel a subunit (SCN4A) gene.Methods Nine patients in a family presented periodic paralysis in an inheritance pattern of autosomal dominant.Except for 1 deceased patient,3 affected individualshad hypokalemic periodic paralysis and 5 showed normokalemic periodic paralysis.Among the patients with normakalemia,4 had muscle stiffness and myalgia;3 showed myotonia discharges in electromyogram explorations,and 1 had worsened weakness after potassium administration.A muscle biopsy was performed in the proband.SCN4A gene mutation screening was carried out in 8 patients.3 asymptomatic family members and 50 health controls.Results Muscle biopsy indicated vacuolar myopathy with abnormal distribution of oxidative enzyme activity.Genetic analysis revealed novel heterozygous missense mutation G3386A in exon 18 of SCN4A gene.The mutation substituted an arginine for a glutamine at the amino acid site1129(R1129Q).Conclusions Hypokalemic and potassium-sensitive normokalemic periodic paralysis can occur sporadically in different affected family members caused by the novel SCN4A mutation at codon R1129Q.
What problem does this paper attempt to address?